| A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Followin | Phase III | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:T | — | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in P | Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapse | Phase III | rekrutiert |
| A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia | — | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bort | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Plac | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sc | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previous | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People W | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Fa | Phase III | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| Early Catheter-directed Treatment of High Risk Pulmonary Embolism | ohne Phasenangabe | rekrutiert |
| Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell | Phase II | rekrutiert |
| Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Pat | Phase III | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III) | ohne Phasenangabe | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical | — | rekrutiert |
| Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab | Phase II | rekrutiert |
| Neurovascular Product Surveillance Registry | — | rekrutiert |
| Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure ( | — | rekrutiert |
| Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (I | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for | Phase III | rekrutiert |
| REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT) | — | rekrutiert |
| Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD- | Phase III | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Tre | ohne Phasenangabe | rekrutiert |
| Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral | Phase IV | rekrutiert |
| Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced | Phase III | rekrutiert |
| Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resect | Phase III | rekrutiert |
| Surgery for Recurrent Glioblastoma | Phase II | rekrutiert |
| Targeting Real World Usage In Stroke Treatment | — | rekrutiert |
| The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in | — | rekrutiert |
| The Fourth Left Atrial Appendage Occlusion Study | ohne Phasenangabe | rekrutiert |
| The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases | — | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti- | Phase III | rekrutiert |
| WATCHMAN FLX Pro European Registry | — | rekrutiert |